|
業務類別
|
Biotechnology |
|
業務概覽
|
Sutro Biopharma Inc is a clinical-stage drug discovery, development, and manufacturing company. The company manufactures next-generation protein therapeutics for cancer and autoimmune disorders through its proprietary integrated cell-free protein synthesis platform, XpressCF. Products offered by the company include STRO-001 for patients with multiple myeloma and lymphoma and STRO-002 for the treatment of ovarian and endometrial cancers. Company's wholly-owned product candidate is STRO-004, a single homogeneous ADC directed against tissue factor which are developing for the treatment of solid tumors. The company also pipeline contains STRO-006, STRO-00X, STRO-00Y, STRO-003, VAX24, VAX31, and Others. |
| 公司地址
| 111 Oyster Point Boulevard, South San Francisco, CA, USA, 94080 |
| 電話號碼
| +1 650 881-6500 |
| 傳真號碼
| -- |
| 公司網頁
| https://www.sutrobio.com |
| 員工數量
| 137 |
| Mr. David Pauling, J.D.,M.A. |
Chief Administrative Officer and General Counsel |
-- |
22/04/2026 |
| Ms. Jane Chung, R.Ph. |
Director and Chief Executive Officer |
美元 652.00K |
22/04/2026 |
| Mr. Hans-Peter Gerber |
Chief Scientific Officer |
美元 527.53K |
22/04/2026 |
| Mr. Gregory K. Chow, M.B.A. |
Chief Financial Officer and Principal Accounting Officer |
美元 277.08K |
22/04/2026 |
|
|
| Ms. Jane Chung, R.Ph. |
Director and Chief Executive Officer |
22/04/2026 |
| Ms. Heidi Hunter |
Independent Director |
22/04/2026 |
| Mr. Sukhi Jagpal |
Independent Director |
22/04/2026 |
| Dr. Michael Dybbs, PhD |
Independent Director |
22/04/2026 |
| Dr. Jon Marc Wigginton, M.D. |
Independent Director |
22/04/2026 |
| Mr. Joseph M. Lobacki |
Independent Director |
22/04/2026 |
| Mr. Daniel H. Petree |
Independent Director |
22/04/2026 |
| Mr. James P. Panek |
Independent Director |
22/04/2026 |
| Ms. Connie L. Matsui |
Chairman of the Board |
22/04/2026 |
|
|
|
|
